| n (%) | |||
---|---|---|---|---|
High-income countries (n = 76) | Low- and middle-income countries (n = 156) | Total (n = 232) | P-value†(α = 0.0036) | |
Optimising therapeutic antimicrobial use | 43 (56.6) | 105 (67.3) | 148 (63.8) | 0.147 |
Optimising surgical prophylaxis | 38 (50.0) | 91 (58.3) | 129 (55.6) | 0.290 |
Translating PPS results into AMS interventions | 38 (50.0) | 71 (45.5) | 109 (47.0) | 0.615 |
Communicating with prescribers | 35 (46.1) | 61 (39.1) | 96 (41.4) | 0.386 |
Managing difficult-to-treat MDRO infections* | 25 (32.9) | 71 (45.5) | 96 (41.4) | 0.091 |
Identifying the low-hanging fruit for AMS in the hospital | 38 (50.0) | 56 (35.9) | 94 (40.5) | 0.056 |
Translating PPS results into IPC** interventions | 17 (22.4) | 61 (39.1) | 78 (33.6) | 0.017 |
Formulating/revising guidelines | 21 (27.6) | 54 (34.6) | 75 (32.3) | 0.359 |
Performing audit and feedback | 17 (22.4) | 54 (34.6) | 71 (30.6) | 0.081 |
Understanding antimicrobial susceptibility data | 15 (19.7) | 55 (35.3) | 70 (30.2) | 0.024 |
How to create an active stewardship committee/team | 9 (11.8) | 41 (26.3) | 50 (21.6) | 0.019 |
How to communicate with patients on antimicrobial use | 13 (17.1) | 28 (18.0) | 41 (17.7) | 1.000 |
Other learning needs | 1 (1.3) | 2 (1.3) | 3 (1.3) | 1.000 |
None | 2 (2.6) | 0 (0.0) | 2 (0.9) | 0.106 |